Apr 14, 2023 7:00 am EDT MindMed Collaborators Announce Positive Topline Data from Phase 2 Trial of Lysergide (LSD) in Major Depressive Disorder (MDD)
Apr 13, 2023 7:00 am EDT MindMed Appoints Mark R. Sullivan as Chief Legal Officer and Corporate Secretary